ATE166360T1 - Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon - Google Patents

Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon

Info

Publication number
ATE166360T1
ATE166360T1 AT90905299T AT90905299T ATE166360T1 AT E166360 T1 ATE166360 T1 AT E166360T1 AT 90905299 T AT90905299 T AT 90905299T AT 90905299 T AT90905299 T AT 90905299T AT E166360 T1 ATE166360 T1 AT E166360T1
Authority
AT
Austria
Prior art keywords
target gene
hormone
gene specificity
receptor
response
Prior art date
Application number
AT90905299T
Other languages
English (en)
Inventor
Ronal Mark Evans
Kazuhiko Omesono
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE166360T1 publication Critical patent/ATE166360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT90905299T 1989-03-17 1990-03-16 Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon ATE166360T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32524089A 1989-03-17 1989-03-17

Publications (1)

Publication Number Publication Date
ATE166360T1 true ATE166360T1 (de) 1998-06-15

Family

ID=23267026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905299T ATE166360T1 (de) 1989-03-17 1990-03-16 Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon

Country Status (8)

Country Link
US (1) US5597693A (de)
EP (1) EP0463081B1 (de)
JP (1) JPH04505012A (de)
AT (1) ATE166360T1 (de)
AU (1) AU655912B2 (de)
CA (1) CA2047752C (de)
DE (1) DE69032324T2 (de)
WO (1) WO1990011273A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665039B2 (en) * 1987-12-02 1995-12-14 Salk Institute For Biological Studies, The Chimeric receptors and methods for identification
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
US6989242B1 (en) 1992-02-26 2006-01-24 The General Hospital Coporation Car receptors and related molecules and methods
EP0577932A3 (de) * 1992-05-08 1995-04-19 American Cyanamid Co Entwicklung von einem "Screening" für den Nachweis von androgenen Rezeptorenagonisten und Antagonisten.
US6242568B1 (en) * 1994-01-18 2001-06-05 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US6140466A (en) * 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US20050084885A1 (en) * 1994-01-18 2005-04-21 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
EP0781331B1 (de) 1994-08-20 2008-09-03 Gendaq Limited Verbesserung in bezug auf bindungsproteine bei der erkennung von dna
US6306649B1 (en) * 1995-06-27 2001-10-23 Ariad Gene Therapeutics, Inc. Heterologous transcription factors
DE792292T1 (de) * 1995-09-08 1998-09-03 Karo Bio Ab, Huddinge Waisen-rezeptor
TR199800657T1 (xx) 1995-10-10 1998-06-22 Novartis Ag J�venil hormon ya da onun agonistlerinden birinin kimyasal ligand olarak resept�r arac�l� transaktivasyon taraf�ndan ger�ekle�tirilen bitkilerdeki gen ekspresyonunu kontrol etmesi.
US6692928B1 (en) 1996-07-19 2004-02-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular agents
US5728534A (en) * 1996-07-19 1998-03-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular therapeutic agents
GB9710809D0 (en) * 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US5972639A (en) * 1997-07-24 1999-10-26 Irori Fluorescence-based assays for measuring cell proliferation
US6479653B1 (en) * 1997-08-26 2002-11-12 Ariad Gene Therapeutics, Inc. Compositions and method for regulation of transcription
GB9718455D0 (en) * 1997-09-02 1997-11-05 Mcgregor Duncan P Chimeric binding peptide library screening method
US6222015B1 (en) 1997-09-08 2001-04-24 Merck & Co., Inc. Estrogen receptor
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
WO1999045132A1 (en) * 1998-03-02 1999-09-10 Massachusetts Institute Of Technology Poly zinc finger proteins with improved linkers
NZ506987A (en) 1998-03-17 2003-01-31 Sangamo Biosciences Inc Nucleic acid binding proteins
HUP0103993A3 (en) 1998-09-10 2003-10-28 Pioneer Hi Bred Internat Inc D Ecdysone receptors and methods for their use
US6140081A (en) * 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
DE19855013C2 (de) 1998-11-20 2001-09-13 Schering Ag Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
US8713641B1 (en) 1998-12-08 2014-04-29 Nomadix, Inc. Systems and methods for authorizing, authenticating and accounting users having transparent computer access to a network using a gateway device
US8266266B2 (en) 1998-12-08 2012-09-11 Nomadix, Inc. Systems and methods for providing dynamic network authorization, authentication and accounting
US6599692B1 (en) * 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6534261B1 (en) * 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
DE19907099A1 (de) * 1999-02-19 2000-09-07 Theragene Biomedical Lab Gmbh Hormon-Hormonrezeptorkomplexe und Nukleinsäurekonstrukte und ihre Verwendung in der Gentherapie
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US7030215B2 (en) * 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US20030104526A1 (en) * 1999-03-24 2003-06-05 Qiang Liu Position dependent recognition of GNN nucleotide triplets by zinc fingers
US20020132223A1 (en) * 1999-03-26 2002-09-19 City Of Hope Methods for modulating activity of the FXR nuclear receptor
US6548739B2 (en) * 1999-06-18 2003-04-15 City Of Hope Method for activating peroxisome proliferator activated receptor-γ
US6586189B2 (en) 1999-06-18 2003-07-01 City Of Hope Screening method for PPAR-γ ligands
AU776576B2 (en) * 1999-12-06 2004-09-16 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
ATE355368T1 (de) * 2000-01-24 2006-03-15 Gendaq Ltd Nucleinsäure bindende polypeptide gekennzeichnet durch flexible linker verbundene nucleinsäuredomäne
AU2001252944A1 (en) * 2000-03-24 2001-10-08 City Of Hope Methods of modulating drug clearance mechanisms by altering SXR activity
WO2002061102A2 (en) 2000-10-24 2002-08-08 Syngenta Participations Ag Control of gene expression in plants
US7026462B2 (en) * 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) * 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
CA2435394C (en) * 2001-01-22 2018-01-09 Sangamo Biosciences, Inc. Modified zinc finger binding proteins
US7067617B2 (en) * 2001-02-21 2006-06-27 The Scripps Research Institute Zinc finger binding domains for nucleotide sequence ANN
AU2002333682A1 (en) * 2001-08-02 2003-02-17 Gencell S.A. Inducible expression systems employing ppar transcriptional activators
EP1288303A1 (de) * 2001-08-23 2003-03-05 Aventis Pharma S.A. Induzierbare Expressionssysteme unter Verwendung von PPAR Transkriptionsaktivatoren
US7262054B2 (en) * 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7361635B2 (en) * 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5274077A (en) * 1987-12-02 1993-12-28 The Salk Institute For Biological Studies Retinoic acid receptor composition
US5171671A (en) * 1987-12-02 1992-12-15 The Salk Institute For Biological Studies Retinoic acid receptor composition
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method

Also Published As

Publication number Publication date
EP0463081A4 (en) 1992-08-12
DE69032324D1 (de) 1998-06-25
EP0463081A1 (de) 1992-01-02
EP0463081B1 (de) 1998-05-20
AU5342390A (en) 1990-10-22
CA2047752A1 (en) 1990-09-18
DE69032324T2 (de) 1998-10-08
AU655912B2 (en) 1995-01-19
JPH04505012A (ja) 1992-09-03
CA2047752C (en) 2001-07-10
US5597693A (en) 1997-01-28
WO1990011273A1 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
ATE166360T1 (de) Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon
Madan et al. Bidirectional transport of glucocorticoid receptors across the nuclear envelope.
Massague et al. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.
Tada et al. Analysis of competence and of Brachyury autoinduction by use of hormoneinducible Xbra
Malik et al. Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors
Joshi et al. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin
CA2309879C (en) Nuclear hormone receptor drug screens
Greene et al. Immunochemical evaluation of estrogen receptor and progesterone receptor in breast cancer
Yamashita et al. Transcription factor TFIIB sites important for interaction with promoter-bound TFIID
Waeber et al. Nuclear translocation and DNA recognition signals colocalized within the bZIP domain of cyclic adenosine 3′, 5′-monophosphate response element-binding protein CREB
Almenoff et al. Ligand‐based histochemical localization and capture of cells expressing heat‐stable enterotoxin receptors
IT1177968B (it) Recettori monoclonali, indotti da polipeptidi,per leganti proteinici
ATE153769T1 (de) Prüfungskit
Kakinuma et al. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies
Whitlock The control of cytochrome P-450 gene expression by dioxin
Burnett et al. Immunohistochemistry for light microscopy in safety evaluation of therapeutic agents: an overview
Kwon et al. Tumor necrosis factor alpha induction of NF-κB requires the novel coactivator SIMPL
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
ATE142339T1 (de) Verfahren zur bestimmung der menge eines schilddrüsenhormon-liganden in einer biologischen flüssigkeit und satz zur durchführung dieses verfahrens
Casey et al. Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein–Barr virus infection
US6555326B1 (en) Nuclear hormone receptor fluorescence polarization assay
Silver et al. Production and characterization of antisera against three individual NHC proteins; a case of a generally distributed NHC protein
Gesnel et al. Cooperative binding of TIA-1 and U1 snRNP in K-SAM exon splicing activation
ES2112211A1 (es) Procedimiento para el estudio del ciclo celular de subpoblaciones de celulas presentes en muestras celulares heterogeneas.
Poor et al. Visualization of multiple protein bands on the same nitrocellulose membrane by double immunoblotting

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties